Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled time : 14:00 save search
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
asco tumors treatment blood for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: 4.72%
H: 0.0%
C: 0.0%
fda opioid approval treatment for spray
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
ARWR | $23.285 -2.08% -2.13% 810K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
disease kidney treatment pharmaceuticals for study
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.0%
H: 1.92%
C: 1.0%
emblaveo treatment for infections
Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
ACAD | News | $16.57 -1.02% -1.03% 1.3M
|
Health Technology
|
| O: 1.37%
H: 1.7%
C: -0.35%
drug health review treatment pharmaceuticals for canada submission
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: -1.24%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
VRNA | $15.21 -2.44% -2.5% 320K
|
Health Technology
|
| O: 1.65%
H: 2.43%
C: 0.87%
reach treatment research market
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
Published: 2024-04-11 (Crawled : 14:00) - globenewswire.com
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: -1.08%
H: 1.63%
C: -2.72%
first solution light treatment for study
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
Published: 2024-03-25 (Crawled : 14:00) - globenewswire.com
SABS | $4.36 7.54% 730
|
|
| O: 1.43%
H: 0.0%
C: -14.14%
partnership influenza treatment research medical potential
Hyperpigmentation Treatment Market to Reach $10.5 Billion, Globally, by 2032 at 7.5% CAGR: Allied Market Research
Published: 2024-03-11 (Crawled : 14:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
reach treatment research market
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
Published: 2024-03-05 (Crawled : 14:00) - globenewswire.com
OPK | $1.225 -2.0% -2.04% 6.1M
|
Health Technology
|
| O: -0.96%
H: 1.98%
C: -5.6%
antibody group treatment hiv trial results study
FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
HUGE | News | $0.4634 -5.24% -5.52% 280K
|
Process Industries
|
| O: -13.48%
H: 15.52%
C: 12.05%
pharma positive sclerosis treatment research results lucid-21-302 study
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Published: 2024-02-29 (Crawled : 14:00) - globenewswire.com
TENX | $3.51 0.29% 0.28% 7.9K
|
Health Technology
|
| O: 1.69%
H: 12.35%
C: 9.03%
levosimendan presentation treatment therapeutics
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
Published: 2024-02-28 (Crawled : 14:00) - globenewswire.com
FEMY | $1.33 0.0% 110K
|
Manufacturing
|
| O: 6.17%
H: 9.3%
C: 2.91%
fda femaseed treatment clearance alternative
Edgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conference
Published: 2024-02-28 (Crawled : 14:00) - biospace.com/
EWTX | $16.08 2.75% 2.67% 430K
|
Manufacturing
|
| O: 0.42%
H: 1.0%
C: -1.6%
edg-5506 conference treatment therapeutics
Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹
Published: 2024-02-20 (Crawled : 14:00) - globenewswire.com
SCLX | $0.8407 -13.92% -16.18% 1.7M
|
|
| O: 0.53%
H: 4.79%
C: -3.72%
ztlido company anesthesiology publication treatment research results study
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis
Published: 2024-02-19 (Crawled : 14:00) - prnewswire.com
OCUL | News | $4.645 -7.1% -7.64% 3.9M
|
Health Technology
| Email alert
Add to watchlist
dextenza drug health ocular treatment sciences application therapeutics
LiqTech Enters Distribution Agreement with Razorback Direct for Commercialization of LiqTech Produced Water Treatment Solution in the U.S.
Published: 2024-02-14 (Crawled : 14:00) - prnewswire.com
LIQT | $2.6 -3.0% 5.2K
|
Producer Manufacturing
|
| O: 1.85%
H: 3.69%
C: 2.47%
water solution distribution direct treatment commercialization agreement
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Published: 2024-02-13 (Crawled : 14:00) - biospace.com/
LCTX | $1.1 -3.51% 0.0% 740K
|
Health Technology
|
| O: 1.85%
H: 0.83%
C: -7.27%
fda cell treatment clearance
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
Published: 2024-02-12 (Crawled : 14:00) - prnewswire.com
KTRA | $0.1374 3.54% 3.42% 5.8M
|
Distribution Services
|
| O: 10.84%
H: 0.58%
C: -14.49%
rem-001 breast cancer treatment trial therapeutics
FDA Approves Takeda’s EOHILIA (budesonide oral suspension), the First and Only Oral Treatment in the U.S. for Eosinophilic Esophagitis (EoE)
Published: 2024-02-12 (Crawled : 14:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.07%
H: 0.46%
C: 0.42%
fda first treatment
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.